p-aminohippuric acid has been researched along with Disease Models, Animal in 18 studies
p-Aminohippuric Acid: The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity.
p-aminohippurate : A hippurate that is the conjugate base of p-aminohippuric acid, arising from deprotonation of the carboxy group.
p-aminohippuric acid : An N-acylglycine that is the 4-amino derivative of hippuric acid; used as a diagnostic agent in the measurement of renal plasma flow.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vascular calcification was induced by administration of a single dose of vitamin D(3) (300,000 UI/ kg b." | 1.38 | Renal expression and function of oat1 and oat3 in rats with vascular calcification. ( Bulacio, R; Hazelhoff, MH; Torres, AM, 2012) |
| "However, their changes in chronic renal failure (CRF) are poorly understood." | 1.31 | Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. ( Inui, K; Ji, L; Masuda, S; Saito, H, 2002) |
| "Normocapnic hypoxemia (PaO2 = 38." | 1.27 | The newborn rabbit: a model for studying hypoxemia-induced renal changes. ( Gouyon, JB; Guignard, JP; Vallotton, M, 1987) |
| "Polyuria was induced by: (1) saline-bicarbonate infusion; (2) furosemide with saline-bicarbonate infusion to replace urine losses; (3) massive infusion of mannitol." | 1.26 | The participation of the renal tubules to the metabolism of insulin. ( Dubois, R; Franckson, JR; Gassée, JP; Ooms, HA, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Ohtsuki, S | 1 |
| Kikkawa, T | 1 |
| Mori, S | 1 |
| Hori, S | 1 |
| Takanaga, H | 1 |
| Otagiri, M | 1 |
| Terasaki, T | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Ma, YR | 1 |
| Luo, X | 1 |
| Wu, YF | 1 |
| Zhang, T | 1 |
| Zhang, F | 1 |
| Zhang, GQ | 1 |
| Wu, XA | 1 |
| Bulacio, R | 1 |
| Hazelhoff, MH | 1 |
| Torres, AM | 2 |
| Ji, L | 1 |
| Masuda, S | 1 |
| Saito, H | 1 |
| Inui, K | 1 |
| Fleck, M | 1 |
| Appenroth, D | 3 |
| Malich, A | 1 |
| Stein, G | 1 |
| Fleck, C | 3 |
| Guignard, JP | 2 |
| Beutinger, R | 1 |
| Lupp, A | 1 |
| Sutter, L | 1 |
| Koch, B | 1 |
| Meinhold, T | 1 |
| Pitack, M | 1 |
| Gasser, R | 1 |
| Li, Q | 1 |
| Bowmer, CJ | 1 |
| Yates, MS | 1 |
| Tanner, GA | 1 |
| Gretz, N | 1 |
| Shao, Y | 1 |
| Evan, AP | 1 |
| Steinhausen, M | 1 |
| Montagna, G | 1 |
| Hofer, CG | 1 |
| Easterling, TR | 1 |
| Van Hook, J | 1 |
| Roberts, B | 1 |
| Koerker, D | 1 |
| Lindheimer, MD | 1 |
| Koeppen, B | 1 |
| Katz, AL | 1 |
| Freeman, RH | 1 |
| Davis, JO | 1 |
| Williams, GM | 1 |
| DeForrest, JM | 1 |
| Seymour, AA | 1 |
| Rowe, BP | 1 |
| Mályusz, M | 1 |
| Laucht, R | 1 |
| Gutsche, HU | 1 |
| Rumpf, KW | 1 |
| Franckson, JR | 1 |
| Gassée, JP | 1 |
| Ooms, HA | 1 |
| Dubois, R | 1 |
| Gouyon, JB | 1 |
| Vallotton, M | 1 |
18 other studies available for p-aminohippuric acid and Disease Models, Animal
| Article | Year |
|---|---|
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Ma | 2004 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Alteration of renal excretion pathways in gentamicin-induced renal injury in rats.
Topics: Acute Kidney Injury; Animals; Antiporters; ATP Binding Cassette Transporter, Subfamily G, Member 2; | 2018 |
Renal expression and function of oat1 and oat3 in rats with vascular calcification.
Topics: Animals; Aorta, Abdominal; Arterial Pressure; Calcium; Cell Membrane; Cholecalciferol; Disease Model | 2012 |
Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.
Topics: Animals; Cimetidine; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Estradiol; Gonadal | 2002 |
Renal interstitial fibrosis (RIF): II. Ultrasound follow up study of single uranyl nitrate administration causing renal dysfunction in rats--comparison with histologic and functional renal parameters.
Topics: Acute Disease; Animals; Creatinine; Disease Models, Animal; Female; Fibrosis; Follow-Up Studies; Glu | 2002 |
The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Cycloox | 2002 |
Effects of a therapy with losartan and quinaprilat on the progression of chronic renal failure in rats after a single dose of uranyl nitrate or 5/6 nephrectomy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease | 2003 |
Use of gene chip technology for the characterisation of the regulation of renal transport processes and of nephrotoxicity in rats.
Topics: Aging; Animals; Biological Transport; Dexamethasone; Disease Models, Animal; Female; Gene Expression | 2003 |
Amelioration of cisplatin nephrotoxicity with glycine: dose dependency in rats.
Topics: Analysis of Variance; Animals; Cisplatin; Creatinine; Disease Models, Animal; Diuresis; Dose-Respons | 1995 |
Organic anion secretion in polycystic kidney disease.
Topics: Animals; Anions; Disease Models, Animal; Female; Fluoresceins; Heterozygote; Humans; Ion Transport; | 1997 |
Impairment of cellular redox status and membrane protein activities in kidneys from rats with ischemic acute renal failure.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Glucose-6-Phosphatase; Glutathione; Glutathion | 1998 |
The central and renal hemodynamic effects of amino acid infusion in the study of renal reserve in the baboon.
Topics: Amino Acids; Animals; Diabetic Nephropathies; Disease Models, Animal; Female; Glomerular Filtration | 1998 |
Renal function in normal and hypertensive pregnant rats.
Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Extracellul | 1976 |
Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals | 1979 |
Correlation between the NEFA and acetyl-CoA content and the N-acetylation rate of p-aminohippurate in the kidneys of hypertensive Goldblatt rats. Effect of NEFA on the renal N-acetyltransferase activity.
Topics: Acetyl Coenzyme A; Acetylation; Aminohippuric Acids; Animals; Arylamine N-Acetyltransferase; Disease | 1979 |
The participation of the renal tubules to the metabolism of insulin.
Topics: Animals; Blood Chemical Analysis; Blood Pressure; Disease Models, Animal; Dogs; Female; Glomerular F | 1976 |
The newborn rabbit: a model for studying hypoxemia-induced renal changes.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Disease Models, Animal; Humans; Hypoxia; Infant, New | 1987 |